Truist Financial Corp Glaukos Corp Transaction History

Truist Financial Corp

$62.7 Billion
Q4 2024

A detailed history of Truist Financial Corp transactions in Glaukos Corp stock. As of the latest transaction made, Truist Financial Corp holds 7,370 shares of GKOS stock, worth $684,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,370

Previous 12,689 41.92%

Holding current value

$684,746

Previous $1.65 Million 33.15%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$126.42 - $152.67 $672,427 - $812,051	-5,319 Reduced 41.92%	7,370 $1.11 Million
Q3 2024 Nov 13, 2024	SELL	$113.62 - $135.39 $657,746 - $783,772	-5,789 Reduced 31.33%	12,689 $1.65 Million
Q2 2024 Aug 20, 2024	BUY	$89.48 - $118.35 $133,325 - $176,341	1,490 Added 8.77%	18,478 $2.19 Million
Q1 2024 May 10, 2024	SELL	$76.4 - $96.33 $690,274 - $870,341	-9,035 Reduced 34.72%	16,988 $1.6 Million
Q4 2023 Feb 02, 2024	SELL	$59.53 - $85.11 $1.22 Million - $1.74 Million	-20,495 Reduced 44.06%	26,023 $2.07 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $18,345 - $20,958	-265 Reduced 0.57%	46,518 $3.5 Million
Q2 2023 Aug 01, 2023	BUY	$45.44 - $71.21 $167,264 - $262,124	3,681 Added 8.54%	46,783 $3.33 Million
Q1 2023 May 05, 2023	BUY	$43.88 - $52.48 $286,755 - $342,956	6,535 Added 17.87%	43,102 $2.16 Million
Q4 2022 Feb 17, 2023	SELL	$40.82 - $57.75 $108,622 - $153,672	-2,661 Reduced 6.78%	36,567 $1.6 Million
Q3 2022 Oct 26, 2022	BUY	$46.84 - $58.49 $662,083 - $826,756	14,135 Added 56.33%	39,228 $2.09 Million
Q2 2022 Jul 22, 2022	BUY	$34.86 - $63.77 $5,403 - $9,884	155 Added 0.62%	25,093 $1.14 Million
Q1 2022 Apr 22, 2022	BUY	$44.33 - $57.82 $224,442 - $292,742	5,063 Added 25.47%	24,938 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $113,641 - $160,825	-2,822 Reduced 12.43%	19,875 $883,000
Q3 2021 Nov 05, 2021	BUY	$47.43 - $84.23 $33,438 - $59,382	705 Added 3.21%	22,697 $1.09 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $114,046 - $152,509	1,561 Added 7.64%	21,992 $1.87 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $718,104 - $993,294	10,196 Added 99.62%	20,431 $1.72 Million
Q4 2020 Nov 19, 2021	SELL	$48.9 - $75.26 $150,220 - $231,198	-3,072 Reduced 23.09%	10,235 $770,000
Q4 2020 Feb 18, 2021	SELL	$48.9 - $75.26 $173,448 - $266,947	-3,547 Reduced 21.05%	13,307 $1 Million
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $91,139 - $124,774	-2,448 Reduced 12.68%	16,854 $835,000
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $113,565 - $184,791	-3,946 Reduced 16.97%	19,302 $742,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $34,465 - $94,689	-1,350 Reduced 5.49%	23,248 $718,000
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $1.33 Million - $1.61 Million	24,598 New	24,598 $1.34 Million

Others Institutions Holding GKOS

# of Institutions

350

Shares Held

48M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.42B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Glaukos Corp Transaction History